Dose Escalation Study of EC D-3263 HCl in Advanced Solid Tumors

Status:
Completed

Trial end date:
2012-04-01

Target enrollment:

Participant gender:

This is a Phase 1, dose escalation study evaluating safety and pharmacokinetics of enteric coated D-3263 HCl in subjects with advanced solid tumors

Phase 1

Dendreon